MetLife price target raised to $101 from $97 at Morgan Stanley

Morgan Stanley raised the firm’s price target on MetLife (MET) to $101 from $97 and keeps an Overweight rating on the shares. Lower interest rates and a steady or better equity market should serve as the broader macro backdrops and 2026 should see “similar fundamental trends as 2025,” the analyst tells investors in a life insurance group outlook note.